Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Sci Rep ; 14(1): 3768, 2024 02 14.
Article in English | MEDLINE | ID: mdl-38355966

ABSTRACT

Neuroblastoma (NB) is the most common pediatric tumor and is currently treated by several types of therapies including chemotherapies, such as bortezomib treatment. However, resistance to bortezomib is frequently observed by mechanisms that remain to be deciphered. Bortezomib treatment leads to caspase activation and aggresome formation. Using models of patients-derived NB cell lines with different levels of sensitivity to bortezomib, we show that the activated form of caspase 3 accumulates within aggresomes of NB resistant cells leading to an impairment of bortezomib-induced apoptosis and increased cell survival. Our findings unveil a new mechanism of resistance to chemotherapy based on an altered subcellular distribution of the executioner caspase 3. This mechanism could explain the resistance developed in NB patients treated with bortezomib, emphasizing the potential of drugs targeting aggresomes.


Subject(s)
Antineoplastic Agents , Neuroblastoma , Child , Humans , Bortezomib/pharmacology , Bortezomib/therapeutic use , Caspase 3/pharmacology , Cell Line, Tumor , Apoptosis , Neuroblastoma/drug therapy , Neuroblastoma/pathology , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use
3.
Cell Metab ; 33(6): 1124-1136.e5, 2021 06 01.
Article in English | MEDLINE | ID: mdl-33811820

ABSTRACT

Cellular senescence is a stress or damage response that causes a permanent proliferative arrest and secretion of numerous factors with potent biological activities. This senescence-associated secretory phenotype (SASP) has been characterized largely for secreted proteins that participate in embryogenesis, wound healing, inflammation, and many age-related pathologies. By contrast, lipid components of the SASP are understudied. We show that senescent cells activate the biosynthesis of several oxylipins that promote segments of the SASP and reinforce the proliferative arrest. Notably, senescent cells synthesize and accumulate an unstudied intracellular prostaglandin, 1a,1b-dihomo-15-deoxy-delta-12,14-prostaglandin J2. Released 15-deoxy-delta-12,14-prostaglandin J2 is a biomarker of senolysis in culture and in vivo. This and other prostaglandin D2-related lipids promote the senescence arrest and SASP by activating RAS signaling. These data identify an important aspect of cellular senescence and a method to detect senolysis.


Subject(s)
Oxylipins/metabolism , Senescence-Associated Secretory Phenotype , Senotherapeutics/metabolism , Animals , Biomarkers/metabolism , Cell Line , Humans , Mice , Mice, Inbred C57BL
SELECTION OF CITATIONS
SEARCH DETAIL
...